Haemonetics develops blood- and plasma-management technologies for hospitals, blood centers and plasma collectors. Its portfolio includes apheresis systems, software and consumables used in transfusion medicine, plasma collection and surgical blood management. The company sits at the intersection of medical devices and workflow software for blood supply chains.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 330.6 | — | 58 | — |
| Q2 2025 | 321.4 | — | 34 | — |
| Q3 2025 | 327.3 | — | 38.7 | — |
| Q4 2025 | 339 | — | 44.7 | — |
| Q1 2026 | 346.4 | 4.8% | -20.1 | -134.8% |
| Q2 2026 | 339.4 | 5.6% | 33 | -3% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Vail Resorts, Inc. (MTN), Hafnia Limited (HAFN), OUTFRONT Media Inc. (OUT), Ameris Bancorp (ABCB), AutoNation, Inc. (AN), Brookfield Renewable Corporation (BEPC)